Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 757.47 | 54.74 | 711.03 | ||
| High | 774.26 | 55.20 | 721.84 | ||
| Low | 755.80 | 54.37 | 708.10 | ||
| Latest | 768.49 | 54.79 | 729.02 | ||
| Change | +19.20 | +0.56 | +24.71 | ||
| % Change | +2.56% | +1.03% | +3.51% | ||
| Volume | 161,826 | 2,754,975 | 140,573 | ||
| 20-Day Average Volume | 567,524 | 4,722,288 | 343,841 | ||
| Previous Close | 749.29 | 54.23 | 704.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 754.95 | 53.99 | 706.23 | ||
| 20-Day Raw Stochastic | 57.10% | 54.33% | 61.85% | ||
| 20-Day Relative Strength | 51.43 | 50.42 | 44.52 | ||
| Weighted Alpha | +36.85 | +49.52 | +19.05 | ||
| Today's Opinion | 72% Buy | 56% Buy | 56% Sell | ||
| Previous Opinion | 24% Buy | 56% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.04% since 03/24/26 | +2.97% since 03/24/26 | +6.44% since 03/24/26 | ||
| Low | 736.64 on 03/27/26 | 53.79 on 03/27/26 | 685.68 on 03/25/26 | ||
| High | 773.57 on 03/31/26 | 55.16 on 03/31/26 | 721.60 on 03/31/26 | ||
| 1-Month | |||||
| %Chg | -2.23% since 02/27/26 | -7.79% since 02/27/26 | -5.97% since 02/27/26 | ||
| Low | 727.88 on 03/19/26 | 51.54 on 03/20/26 | 661.85 on 03/20/26 | ||
| High | 794.77 on 03/03/26 | 58.87 on 03/02/26 | 766.19 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -2.64% since 12/26/25 | +11.09% since 12/26/25 | -14.65% since 12/26/25 | ||
| Low | 718.38 on 01/20/26 | 47.62 on 01/20/26 | 661.85 on 03/20/26 | ||
| High | 821.11 on 01/09/26 | 61.69 on 02/18/26 | 881.89 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +35.53% since 09/26/25 | +36.83% since 09/26/25 | +1.34% since 09/26/25 | ||
| Low | 541.00 on 10/13/25 | 40.36 on 09/29/25 | 661.85 on 03/20/26 | ||
| High | 821.11 on 01/09/26 | 61.69 on 02/18/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 79,214,936 | 110,167,000 | 43,584,808 | ||
| Shares Outstanding, K | 105,720 | 2,031,477 | 61,883 | ||
| Annual Sales | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Quarter Sales | 3,884,300,000 | 11,424,970,000 | 1,322,160,000 | ||
| Last Quarter Net Income | 844,600,000 | 851,670,000 | 532,950,000 | ||
| 60-Month Beta | 0.40 | 0.44 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 11.44 on 01/30/26 | 0.68 on 02/04/26 | 8.02 on 02/26/26 | ||
| Latest Earnings Date | 04/29/26 | 04/29/26 | 05/14/26 | ||
| Most Recent Dividend | 0.940 on 02/20/26 | 0.478 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | 02/20/26 | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.45 | 11.91 | 35.42 | ||